| scholarly article | Q13442814 |
| P50 | author | Robert Torka | Q74720124 |
| P2093 | author name string | Anja Weber | |
| Markus Lauter | |||
| P2860 | cites work | PMA up-regulates the transcription of Axl by AP-1 transcription factor binding to TRE sequences via the MAPK cascade in leukaemia cells | Q39639728 |
| Molecular analysis of alternative transcripts of equine AXL receptor tyrosine kinase gene | Q41600499 | ||
| Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL receptor tyrosine kinase degradation | Q42155234 | ||
| GAS6-expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistance. | Q42288454 | ||
| Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity | Q42408081 | ||
| Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis | Q42502708 | ||
| Cytoplasmic ACK1 interaction with multiple receptor tyrosine kinases is mediated by Grb2: an analysis of ACK1 effects on Axl signaling | Q42693450 | ||
| Effects of Gas6 and hydrogen peroxide in Axl ubiquitination and downregulation | Q46548747 | ||
| The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study | Q47411655 | ||
| Targeting Gas6/TAM in cancer cells and tumor microenvironment | Q47701436 | ||
| The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression. | Q53069540 | ||
| The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer. | Q54298179 | ||
| Phyllodes tumor of the breast: role of Axl and ST6GalNAcII in the development of mammary phyllodes tumors. | Q55073541 | ||
| Axl inhibitor R428 induces apoptosis of cancer cells by blocking lysosomal acidification and recycling independent of Axl inhibition | Q58804596 | ||
| Intracellular signaling of the Ufo/Axl receptor tyrosine kinase is mediated mainly by a multi-substrate docking-site | Q24309038 | ||
| Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice | Q24810598 | ||
| Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein | Q28210330 | ||
| Grb2 regulates internalization of EGF receptors through clathrin-coated pits | Q30164836 | ||
| The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells. | Q33357894 | ||
| Writers and readers of histone acetylation: structure, mechanism, and inhibition | Q33796362 | ||
| Activation of HER3 interferes with antitumor effects of Axl receptor tyrosine kinase inhibitors: suggestion of combination therapy. | Q33891230 | ||
| Diversification of TAM receptor tyrosine kinase function | Q34214465 | ||
| Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET. | Q34217927 | ||
| Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts | Q34380670 | ||
| Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities | Q34390266 | ||
| SOMA: a single oligonucleotide mutagenesis and cloning approach | Q34764129 | ||
| Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden. | Q34797452 | ||
| Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma. | Q35669106 | ||
| Aberrant mRNA translation in cancer pathogenesis: an old concept revisited comes finally of age. | Q35750097 | ||
| Targeting the degradation of AXL receptor tyrosine kinase to overcome resistance in gefitinib-resistant non-small cell lung cancer | Q35832938 | ||
| Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA | Q36054278 | ||
| Combined inhibition of AXL, Lyn and p130Cas kinases block migration of triple negative breast cancer cells | Q36214760 | ||
| Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases | Q36493822 | ||
| Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase | Q36556713 | ||
| Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance | Q37380418 | ||
| Specific Grb2-mediated interactions regulate clathrin-dependent endocytosis of the cMet-tyrosine kinase | Q38302515 | ||
| Histone exchange, chromatin structure and the regulation of transcription | Q38343838 | ||
| AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective | Q38629669 | ||
| Giving AXL the axe: targeting AXL in human malignancy | Q38772267 | ||
| Translation Initiation Factors: Reprogramming Protein Synthesis in Cancer | Q38899989 | ||
| Axl glycosylation mediates tumor cell proliferation, invasion and lymphatic metastasis in murine hepatocellular carcinoma | Q39256469 | ||
| TAM Receptor Tyrosine Kinases in Cancer Drug Resistance | Q39319172 | ||
| AXL-Driven EMT State as a Targetable Conduit in Cancer | Q39408053 | ||
| Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer | Q39592978 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 59 | |
| P577 | publication date | 2019-06-06 | |
| P1433 | published in | Cell Communication and Signaling | Q1254390 |
| P1476 | title | Targeting of the AXL receptor tyrosine kinase by small molecule inhibitor leads to AXL cell surface accumulation by impairing the ubiquitin-dependent receptor degradation | |
| P478 | volume | 17 |
Search more.